Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
3.340
+0.060 (1.83%)
May 13, 2026, 9:33 AM EDT - Market open
Clover Health Investments Revenue
Clover Health Investments had revenue of $749.19M in the quarter ending March 31, 2026, with 62.05% growth. This brings the company's revenue in the last twelve months to $2.21B, up 48.75% year-over-year. In the year 2025, Clover Health Investments had annual revenue of $1.92B with 40.34% growth.
Revenue (ttm)
$2.21B
Revenue Growth
+48.75%
P/S Ratio
0.78
Revenue / Employee
$3,052,992
Employees
724
Market Cap
1.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.92B | 553.18M | 40.34% |
| Dec 31, 2024 | 1.37B | 110.59M | 8.77% |
| Dec 31, 2023 | 1.26B | 163.99M | 14.96% |
| Dec 31, 2022 | 1.10B | -375.45M | -25.51% |
| Dec 31, 2021 | 1.47B | 799.11M | 118.76% |
| Dec 31, 2020 | 672.89M | 210.62M | 45.56% |
| Dec 31, 2019 | 462.27M | 172.70M | 59.64% |
| Dec 31, 2018 | 289.57M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 449.71B |
| CVS Health | 405.62B |
| The Cigna Group | 277.89B |
| Elevance Health | 200.42B |
| Centene | 178.33B |
| Humana | 137.20B |
| Molina Healthcare | 43.10B |
| Oscar Health | 13.30B |
CLOV News
- 6 days ago - Clover Health Investments Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Clover Health Reports First Quarter 2026 Results - GlobeNewsWire
- 4 weeks ago - Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026 - GlobeNewsWire
- 5 weeks ago - Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership - GlobeNewsWire
- 6 weeks ago - Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 - GlobeNewsWire
- 7 weeks ago - Clover Health price target lowered to $3.20 from $3.70 at Canaccord - TheFly
- 7 weeks ago - Clover Health’s Counterpart Assistant associated with decrease in flu events - TheFly
- 7 weeks ago - Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients - GlobeNewsWire